Autoimmune diseases are characterized by inflammatory reactions caused by the hyperactive immune response of the body due to damage to own cells and body tissues. There are more than 80 types of autoimmune diseases prevalent in men and women. According to the National Institute of Health (NIH), autoimmune diseases are among the top ten causes of death in women in the U.S. Autoimmune disease diagnostics include the diagnostics procedures and tests that assist in identification of disease type and stage. Symptoms associated with autoimmune diseases include fatigue, inflammation, fever, rashes, and joint pain. The increasing prevalence of autoimmune diseases, rising public awareness and supportive government policies are the major factors driving the global autoimmune disease diagnostics market. According to the American Autoimmune Related Diseases Association (AARDA), currently, 50 million people in the U.S. are living with autoimmune diseases. In addition, advancement in diagnostic procedures, improved laboratory techniques and growing healthcare expenditure across the world are also expected to propel the market of autoimmune disease diagnostics. For instance, government organizations across the world are increasing their spending to provide better health care services. For instance, an analysis based on preliminary government data by the Centers for Medicare & Medicaid Services revealed that health care spending in the U.S. increased by 5% in 2014 as compared to 3.6% in 2013.
Request a Sample Copy of the Report @ http://www.mrrse.com/sample/1538
The global autoimmune disease diagnostics market has been estimated on the basis of test types and diseases. The market for autoimmune disease diagnostics is divided into eight segments on the basis of tests: antinuclear antibody test, autoantibody test, complete blood count, comprehensive metabolic panel, C-reactive protein test, erythrocyte sedimentation rate, urinalysis and others. Autoantibody tests accounted for the largest market share in 2014 in terms of revenue and continues to dominate the market due to high sensitivity and specificity. Moreover, the main advantages of antibody-based tests are their speed, simplicity, and minimal patient discomfort.
On the basis of disease the autoimmune disease diagnostics market is categorized into seven segments: Graves’ disease, Hashimotos’s thyroiditis, rheumatoid arthritis, multiple sclerosis, type 1 diabetes, systemic lupus erythematosus and others. Rheumatoid arthritis accounted for the largest market share in 2014 in terms of revenue and continues to dominate the market due to the rising prevalence of rheumatoid arthritis across the world and improved laboratory tests for the diagnosis of rheumatoid arthritis
Inquiry on this report @ http://www.mrrse.com/enquiry/1538
Geographically, autoimmune disease diagnostics market has been segmented into four major regions: North America, Europe, Asia-Pacific, and Rest of the World. North America held the largest share of 39.0% of the global autoimmune disease diagnostics market in terms of revenue in 2014 followed by Europe. Rising patient population, presence of major players and well-structured distribution channel are driving the growth of these regions. Asia Pacific was the third largest market for autoimmune disease diagnostics, and is expected to register the fastest CAGR during the forecast period. Large untapped opportunities, improving health care infrastructure, increasing prevalence of autoimmune diseases, and expansion of market players in the region would contribute to the market growth.
Read Complete Report with TOC @ http://www.mrrse.com/autoimmune-disease-diagnostics-market
Abbott Laboratories, Beckman Coulter, Inc., F. Hoffmann-La Roche Ltd., Bio- Rad laboratories, bioMerieux, Siemens Healthcare, Inova Diagnostics, Inc., Quest Diagnostics, and SQL Diagnostics, Inc. are some of the major players operating in the global autoimmune disease diagnostics market. Most of these players are constantly striving to retain or enhance their market share by developing technologically advanced products.
90 State Street,
Albany NY – 12207